Cannabis use in liver transplant candidates and recipients

Liver Transpl. 2024 Jan 31. doi: 10.1097/LVT.0000000000000335. Online ahead of print.

ABSTRACT

The increasing legality and acceptance of cannabis sale and consumption across the United States has led to a measurable increase in cannabis use nationwide, including in liver transplant (LT) candidates and recipients. With over 75% of LT recipients transplanted in states with legalized use of medicinal and/or recreational cannabis, LT clinicians must have expertise in assessment of cannabis use given its potential impact on clinical care. In this review, we provide an understanding of nomenclature and tools to assess cannabis use, highlight essential components to guide clinical policy development and implementation, and discuss potential impacts of cannabis use on patients’ transplant course.

PMID:38289264 | DOI:10.1097/LVT.0000000000000335